E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/5/2007 in the Prospect News Convertibles Daily.

New Issue: Hologic prices upsized $1.5 billion convertible senior notes due 2037; initial 2% coupon, up 25%

By Evan Weinberger

New York, Dec. 5 - Hologic, Inc. priced an upsized $1.5 billion in convertible senior notes due Dec. 15, 2037 with a 25% initial conversion premium Tuesday after market close. The convertibles will carry a 2% cash coupon for the first six years.

Beginning in 2013, the convertibles will accrete at a 2% rate with a contingent cash coupon of 0.4% of the trading price subject to a 120% threshold.

The deal came in at the mid range of talk, which had been a 1.75% to 2.25% initial coupon and a 22.5% to 27.5% initial conversion premium. The deal was originally announced at $1.3 billion in principal amount.

Goldman Sachs is the bookrunner of the registered transaction.

There is an upsized $225 million over-allotment option. The greenshoe was originally announced at $195 million.

The settlement date is expected to be Dec. 10.

The conversion price is $77.1875 and the conversion ratio is 12.9555.

The convertibles are callable beginning Dec. 18, 2013 at 100%. There are put options on Dec. 13, 2013 and Dec. 18 in each of 2017, 2022, 2027 and 2032.

The convertibles have full dividend protection in the form of a conversion ratio adjustment. There is fundamental change protection, but no public acquirer change of control waiver.

Hologic is a Bedford, Mass.-based is a diagnostic and medical product and device maker that focuses on women's health. Proceeds from the convertibles will go toward repayment of outstanding senior secured debt.

Issuer: Hologic, Inc.

Issue: Convertible senior notes

Amount: $1.5 billion

Greenshoe: $225 million

Maturity:Dec. 15, 2037
Coupon: 2% for the first six years, then principal accretes at 2%
Price: Par
Yield:2%
Conversion premium: 25%
Conversion price: $77.1875
Conversion ratio: 12.9555
Contingent payment:120%
Call: Beginning Dec. 18, 2013
Put: Dec. 18, 2013 and Dec. 13 in each of 2017, 2022, 2027 and 2032
Bookrunner: Goldman Sachs
Distribution: SEC registered
Pricing date: Dec. 4
Settlement date: Dec. 10
Talk: 1.75% to 2.25% initial coupon, 22.5% to 27.5% initial conversion premium; $1.3 billion principal; $195 million greenshoe

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.